Loading organizations...
FS Life Science Investment operates as a business angel firm, providing both funding and mentorship to early-stage ventures. The company specializes in identifying and supporting sustainable startups and business ideas, with a particular focus on enterprises within the life sciences sector that are actively addressing climate change and promoting ecological well-being. Their investment strategy is geared towards ventures that promise significant positive impact on the planet.
The firm was co-founded by Dr. Carmen Zirngibl and Dr. Frank Schäfer. Their collective insight, drawn from over sixty years of experience as business owners within the life sciences domain, highlighted a need for expert guidance alongside financial backing for emerging sustainable companies. This extensive background allows them to offer valuable strategic oversight to their portfolio companies.
FS Life Science Investment targets entrepreneurs and nascent companies developing solutions in the sustainable life sciences arena. The company's long-term vision is to foster the growth of businesses that not only achieve commercial success but also contribute meaningfully to environmental protection and global sustainability. They aim to be a pivotal partner for founders dedicated to making a tangible, positive difference.
FS Life Science Investment has 1 tracked investment across 1 company. The latest tracked deal is $930K Pre-Seed in Meliodays Medical in November 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 12, 2025 | Meliodays Medical | $930K Pre-Seed | Capacura | — |